Literature DB >> 18519519

Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.

Maaike de Fost, Carel J M van Noesel, Johannes M F G Aerts, Mario Maas, Ruud G Pöll, Carla E M Hollak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18519519     DOI： 10.3324/haematol.12651

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?

Authors:  Benjamin Fedida; Sébastien Touraine; Jerôme Stirnemann; Nadia Belmatoug; Jean-Denis Laredo; David Petrover
Journal:  Eur Radiol       Date:  2015-04-16       Impact factor: 5.315

Review 2.  Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment.

Authors:  Siavash Piran; Dominick Amato
Journal:  J Inherit Metab Dis       Date:  2010-03-25       Impact factor: 4.982

3.  Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG).

Authors:  R-M Javier; E Hachulla; C Rose; V Gressin; P Chérin; E Noël; C de Roux-Serratrice; D Dobbelaere; A Hartmann; R Jaussaud; P Clerson; B Grosbois; C Roux
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

Review 4.  An overview on bone manifestations in Gaucher disease.

Authors:  Peter Mikosch; Derralynn Hughes
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 5.  Treatment of lysosomal storage disorders: successes and challenges.

Authors:  Carla E M Hollak; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2014-05-13       Impact factor: 4.982

6.  Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.

Authors:  L van Dussen; E J Hendriks; J E M Groener; R G Boot; C E M Hollak; J M F G Aerts
Journal:  J Inherit Metab Dis       Date:  2014-05-16       Impact factor: 4.982

7.  Optimal therapy in Gaucher disease.

Authors:  Ozlem Goker-Alpan
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

8.  Current and emerging pharmacotherapy for Gaucher disease in pediatric populations.

Authors:  Richard Sam; Emory Ryan; Emily Daykin; Ellen Sidransky
Journal:  Expert Opin Pharmacother       Date:  2021-03-25       Impact factor: 4.103

9.  Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage.

Authors:  Anneloes E Bohte; Laura van Dussen; Erik M Akkerman; Aart J Nederveen; Ralph Sinkus; Peter L M Jansen; Jaap Stoker; Carla E M Hollak
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Bone turnover markers in patients with type 1 Gaucher disease.

Authors:  Gaetano Giuffrida; Maria Rocca Cingari; Nunziatina Parrinello; Alessandra Romano; Anna Triolo; Magda Franceschino; Francesco Di Raimondo
Journal:  Hematol Rep       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.